Related Experiment Video

Updated: May 31, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

The role of Tau protein in resistance to paclitaxel

Marta Smoter1, Lubomir Bodnar, Renata Duchnowska

  • 1Klinika Onkologii Kobiet, Wojskowy Instytut Medyczny, Ul. Szaserów 128, Warszawa, Poland. smoterm@wp.pl

Cancer Chemotherapy and Pharmacology
|June 30, 2011
PubMed

Insights

Protein Tau is crucial in cancer cells' resistance to taxanes like paclitaxel. High Tau levels predict poor response to taxane chemotherapy, especially in ER-positive breast cancer, suggesting alternative treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Taxane chemotherapy resistance limits systemic therapy efficacy in cancer patients.
  • Microtubule-associated proteins (MAPs), particularly protein Tau, are key mechanisms in taxane resistance.
  • Protein Tau binds to beta-tubulin, competing with paclitaxel binding.

Purpose of the Study:

  • To review the predictive value of protein Tau expression in patient response to taxane-based chemotherapy.
  • To explore the role of protein Tau in mediating resistance to taxanes.
  • To highlight the potential of Tau as a biomarker for treatment selection.

Main Methods:

  • Literature review of preclinical and clinical studies on protein Tau and taxane response.
  • Analysis of Tau protein's interaction with beta-tubulin and its impact on paclitaxel efficacy.
  • Examination of Tau expression patterns in different cancer types, including ER-positive breast cancer.

Main Results:

  • Low Tau expression in cancer cells correlates with increased sensitivity to paclitaxel.
  • High Tau protein expression in ER-positive breast cancers indicates resistance to taxane chemotherapy.
  • Conversely, high Tau expression suggests sensitivity to hormonal therapy.

Conclusions:

  • Protein Tau expression is a significant predictive factor for taxane response in cancer patients.
  • Understanding Tau's role can optimize patient selection for taxane therapy.
  • Targeting Tau or utilizing it as a biomarker may improve treatment outcomes and personalize chemotherapy regimens.

More Related Videos

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...